Castellan Group’s Labcorp LH Stock Holding History

Castellan Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,455	Closed	-$3.36M	–	71
2021 Q4	$3.36M	Buy	+12,455	New	+$3.08M	2.33%	6

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Castellan Group's LH Position: Q1 2022 in Review

Castellan Group sold out of Labcorp (LH) in Q1 2022, closing a stake of 12,455 shares — an estimated $3.36M sold.

Castellan Group first reported a position in LH in Q4 2021 and held it in 1 quarter. The position peaked at $3.36M in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

Castellan Group reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
Castellan Group sold 12,455 Labcorp shares in Q1 2022, an estimated $3.36M.
Castellan Group first reported a position in Labcorp in Q4 2021 and held it in 1 quarter.
Castellan Group's Labcorp position peaked at $3.36M in Q4 2021.
1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Castellan Group's 13F filing for Q1 2022, filed 23 May 2022.